• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyrimidines Pyrrolo[2,3-d]pyrimidines

1-{4-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}ethan-1-one: A Comprehensive Overview

The compound with CAS No. 1363381-59-2, known as 1-{4-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}ethan-1-one, has garnered significant attention in the field of organic chemistry and pharmacology due to its unique structural properties and potential biological activities. This compound belongs to the class of pyrrolopyrimidines, which are heterocyclic aromatic compounds with a fused pyrrole and pyrimidine ring system. The presence of a chloro substituent at the 4-position of the pyrrolo[2,3-d]pyrimidine ring introduces additional electronic effects and enhances its chemical versatility.

Recent studies have highlighted the importance of pyrrolopyrimidines in drug discovery, particularly in the development of kinase inhibitors and other therapeutic agents. The ethanone group attached to the pyrrolopyrimidine core in this compound plays a crucial role in modulating its pharmacokinetic properties, such as solubility and bioavailability. Researchers have explored the synthesis of this compound through various routes, including microwave-assisted synthesis and catalytic cross-coupling reactions, which have significantly improved the efficiency and scalability of its production.

One of the most promising applications of 1-{4-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}ethan-1-one lies in its potential as an anticancer agent. Preclinical studies have demonstrated that this compound exhibits selective cytotoxicity against various cancer cell lines, including those resistant to conventional chemotherapy. The mechanism of action involves inhibition of key oncogenic pathways and induction of apoptosis in malignant cells. These findings underscore its potential as a novel therapeutic candidate for oncology.

In addition to its anticancer properties, this compound has also shown promise in the treatment of inflammatory diseases. Experimental data indicate that it possesses potent anti-inflammatory activity by modulating cytokine production and inhibiting nuclear factor-kappa B (NF-kB) signaling. This dual functionality makes it a versatile molecule with broad therapeutic applications.

The structural uniqueness of 1-{4-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}ethan-1-one also lends itself to further chemical modifications. Researchers are actively exploring analogs with different substituents to optimize its pharmacodynamic properties and minimize off-target effects. For instance, substitution at the 4-chloro position with other electron-withdrawing or donating groups has been shown to significantly alter its biological activity.

From a synthetic perspective, the development of efficient routes for constructing pyrrolo[2,3-d]pyrimidine frameworks remains a focal point for chemists. Recent advancements in transition metal-catalyzed reactions have enabled the construction of these complex heterocycles with high regioselectivity and yield. These methods not only facilitate the synthesis of this compound but also pave the way for exploring related structures with diverse functional groups.

In conclusion, 1-{4-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}ethan-1-one represents a compelling example of how structural diversity can be harnessed to develop innovative therapeutic agents. Its unique chemical properties, coupled with emerging insights into its biological activities, position it as a valuable asset in both academic research and industrial drug development.

• 858117-12-1(Methanone, (6-chloro-3-pyridinyl)-1H-pyrrolo[2,3-b]pyridin-3-yl-)
• 908287-21-8(4-Chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbaldehyde)
• 1638767-57-3(2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbaldehyde)
• 1260383-22-9(1-{6-chloro-1H-pyrrolo2,3-bpyridin-3-yl}ethan-1-one)
• 1313038-21-9((4-Chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)(phenyl)methanone)
• 1004992-44-2(4-Chloro-5-ethyl-7H-pyrrolo[2,3-d]pyrimidine)
• 908287-26-3(1H-Pyrrolo[2,3-d]pyrimidine, 4-chloro-5-(phenylmethyl)-)
• 1427504-18-4(3-Acetyl-4,6-dichloro-7-azaindole)
• 2229072-23-3(2-{4-chloro-7H-pyrrolo2,3-dpyrimidin-5-yl}acetaldehyde)
• 1111237-78-5(4-chloro-2-methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbaldehyde)